A study to assess the pharmacokinetics of Camizestrant (AZD9833) when Administered Alone and in Combination with Itraconazole

Trial Identifier: D8532C00003
Sponsor:AstraZeneca
Collaborator:
Parexel
NCTID:NCT05551897
Start Date:October 2022
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
GB Harrow, GB, HA1 3UJ